Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats
Tsujimura, Tsuyoshi, Nagamine, Jun, Sugaru, Eiji, Ono-Kishino, Michiko, Tokunaga, Teruhisa, Kitoh, Makoto, Nagata, Ryu, Nakagawa, Tsutomu, Taiji, Mutsuo
Published in Biological & pharmaceutical bulletin (01.12.2009)
Published in Biological & pharmaceutical bulletin (01.12.2009)
Get full text
Journal Article
The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters
Tsujimura, Tsuyoshi, Ono-Kishino, Michiko, Nagamine, Jun, Sugaru, Eiji, Tokunaga, Teruhisa, Kitoh, Makoto, Nagata, Ryu, Nakagawa, Tsutomu, Taiji, Mutsuo
Published in Biomedical Research (2009)
Published in Biomedical Research (2009)
Get full text
Journal Article
Chronic administration of SMP-534 ameliorates renal dysfunction in 5/6 nephrectomized rats
Tsujimura, Tsuyoshi, Nagamine, Jun, Sugaru, Eiji, Nakagawa, Tsutomu, Ono-Kishino, Michiko, Tokunaga, Teruhisa, Kitoh, Makoto, Nagata, Ryu, Taiji, Mutsuo
Published in Nephron. Experimental nephrology (01.01.2008)
Published in Nephron. Experimental nephrology (01.01.2008)
Get more information
Journal Article
Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats
Tsuyoshi TSUJIMURAa, Jun NAGAMINEa, Eiji SUGARUa, Michiko ONO-KISHINOa, Teruhisa TOKUNAGAb, Makoto KITOHc, Ryu NAGATAb, Tsutomu NAKAGAWAa, Mutsuo TAIJIa
Published in Biological & Pharmaceutical Bulletin (2009)
Get full text
Published in Biological & Pharmaceutical Bulletin (2009)
Journal Article
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice
Sugaru, Eiji, Nakagawa, Tsutomu, Ono-Kishino, Michiko, Nagamine, Jun, Tokunaga, Teruhisa, Kitoh, Makoto, Hume, W Ewan, Nagata, Ryu, Taiji, Mutsuo
Published in American journal of physiology. Renal physiology (01.04.2006)
Published in American journal of physiology. Renal physiology (01.04.2006)
Get full text
Journal Article
SMP-534 inhibits TGF-beta-induced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental glomerulonephritis
Sugaru, Eiji, Sakai, Mutsuko, Horigome, Kazuhiko, Tokunaga, Teruhisa, Kitoh, Makoto, Hume, W Ewan, Nagata, Ryu, Nakagawa, Tsutomu, Taiji, Mutsuo
Published in American journal of physiology. Renal physiology (01.11.2005)
Published in American journal of physiology. Renal physiology (01.11.2005)
Get full text
Journal Article
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice
SUGARU, Eiji, NAKAGAWA, Tsutomu, ONO-KISHINO, Michiko, NAGAMINE, Jun, TOKUNAGA, Teruhisa, KITOH, Makoto, EWAN HUME, W, NAGATA, Ryu, TAIJI, Mutsuo
Published in American journal of physiology. Renal physiology (01.04.2006)
Get full text
Published in American journal of physiology. Renal physiology (01.04.2006)
Journal Article
Chronic Administration of SMP-534 Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats
TSUJIMURA, Tsuyoshi, NAGAMINE, Jun, SUGARU, Eiji, NAKAGAWA, Tsutomu, ONO-KISHINO, Michiko, TOKUNAGA, Teruhisa, KITOH, Makoto, NAGATA, Ryu, TAIJI, Mutsuo
Published in Nephron (2015) (2008)
Get full text
Published in Nephron (2015) (2008)
Journal Article
SMP-534 inhibits TGF-β-induced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental glomerulonephritis
SUGARU, Eiji, SAKAI, Mutsuko, HORIGOME, Kazuhiko, TOKUNAGA, Teruhisa, KITOH, Makoto, EWAN HUME, W, NAGATA, Ryu, NAKAGAWA, Tsutomu, TAIJI, Mutsuo
Published in American journal of physiology. Renal physiology (01.11.2005)
Get full text
Published in American journal of physiology. Renal physiology (01.11.2005)
Journal Article
Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice
Sugaru, Eiji, Nakagawa, Tsutomu, Ono-Kishino, Michiko, Nagamine, Jun, Tokunaga, Teruhisa, Kitoh, Makoto, Hume, W Ewan, Nagata, Ryu, Taiji, Mutsuo
Published in Nephron. Experimental nephrology (01.01.2007)
Published in Nephron. Experimental nephrology (01.01.2007)
Get more information
Journal Article
Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (Antifibrotic agent) and losartan in db/db mice
SUGARU, Eiji, NAKAGAWA, Tsutomu, ONO-KISHINO, Michiko, NAGAMINE, Jun, TOKUNAGA, Teruhisa, KITOH, Makoto, HUME, W. Ewan, NAGATA, Ryu, TAIJI, Mutsuo
Published in Nephron (2015) (2007)
Get full text
Published in Nephron (2015) (2007)
Journal Article
Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy
Sugaru, Eiji, Nakagawa, Tsutomu, Ono-Kishino, Michiko, Nagamine, Jun, Tokunaga, Teruhisa, Kitoh, Makoto, Hume, W. Ewan, Nagata, Ryu, Taiji, Mutsuo
Published in American journal of nephrology (01.01.2006)
Published in American journal of nephrology (01.01.2006)
Get full text
Journal Article
PYRROLE DERIVATIVE
MARUTA, KATSUNORI, NAGATA, RYU, USHIRODA, KANTARO, YOSHIDA, KOZO, IWAI, KIYOTAKA, KITOH, MAKOTO
Year of Publication 31.10.2002
Get full text
Year of Publication 31.10.2002
Patent
FIBROSIS INHIBITOR
TOKUNAGA, TERUHISA, NAGAMINE, JUN, NAGATA, RYU, HUME, WILLIAM EWAN, TAIJI, MUTSUO, KISHINO, MICHIKO, NAKAGAWA, TSUTOMU, KITOH, MAKOTO
Year of Publication 07.08.2003
Get full text
Year of Publication 07.08.2003
Patent
Chronic Administration of SMP-534 Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats
Tsujimura, Tsuyoshi, Nagamine, Jun, Sugaru, Eiji, Nakagawa, Tsutomu, Ono-kishino, Michiko, Tokunaga, Teruhisa, Kitoh, Makoto, Nagata, Ryu, Taiji, Mutsuo
Published in Nephron (01.12.2008)
Get full text
Published in Nephron (01.12.2008)
Journal Article
ChemInform Abstract: Development of a New Class of Benzoylpyrrole-Based PPARα/γ Activators
Ushiroda, Kantaro, Maruta, Katsunori, Kitoh, Makoto, Iwai, Kiyotaka, Nagamine, Jun, Tsuchida, Atsushi, Taiji, Mutsuo, Nagata, Ryu
Published in ChemInform (10.05.2011)
Published in ChemInform (10.05.2011)
Get full text
Journal Article